Safety Study of GL-ONC1, an Oncolytic Virus, in Patients With Advanced Solid Tumors
This study is currently recruiting participants.
Verified April 2012 by Genelux Corporation
Sponsor:
Genelux Corporation
Information provided by (Responsible Party):
Genelux Corporation
ClinicalTrials.gov Identifier:
NCT00794131
First received: November 18, 2008
Last updated: April 19, 2012
Last verified: April 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | March 2013 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |